Transformative global leader in ed-tech, biotech and healthcare: pioneering inclusive innovation and empowering multilingual leadership
In an era defined by rapid shifts in technology and global interconnection, few leaders embody the spirit of transformative innovation as compellingly as Yesenia Sevilla. Her journey stands as a testament to what becomes possible when curiosity, cultural depth, and a passion for human centered progress converge. As CEO of CHALK she represents a new class of visionary leader who does not simply navigate multiple industries but reimagines the space between them. Yesenia’s story reveals how diversity of experience can become one of the greatest engines for meaningful change
On Cover
Yesenia sevilla
CEO of CHALK
Yesenia Sevilla currently serves as CEO of CHALK, a Nashville-based organization established in 2024. With over 20 years of leadership experience across ed-tech, biotech, and healthcare industries, she has established herself as a transformative force in cross-industry innovation. Her multicultural heritage spanning Cuba, Spain, Lebanon, Brazil, and Portugal, combined with multilingual capabilities, has enabled her to build successful global business strategies and foster inclusive innovation initiatives.
Janet Uribe Alexander
Founder, Author of Hearts and Minds Learning Center
In the quiet corridors of memory, some experiences leave marks so deep they reshape entire life trajectories. For Janet Uribe Alexander, those marks came early, wrapped in the shame and embarrassment of not being able to read like her peers. What could have remained a childhood wound instead became the foundation for a revolutionary approach to education that has transformed thousands of lives.
Dr. Jennifer Johnston
Founder & CEO of Elle, MD Biotechnologies
In her clinical practice as a family physician, Dr. Jennifer Johnston observed a recurring theme: women expressing a desire for more contraceptive options that better suited their individual needs and lifestyles. This clinical insight, combined with her perspective as a mother of four children—three daughters—sparked the idea that would eventually become Elle, MD Biotechnologies.
